Characterization of the tumour necrosis factor alpha-converting enzyme, TACE/ADAM17

Biochem Soc Trans. 1999 Feb;27(2):219-23. doi: 10.1042/bst0270219.
No abstract available

Publication types

  • Review

MeSH terms

  • ADAM Proteins
  • ADAM17 Protein
  • Amino Acid Sequence
  • Animals
  • Cell Line
  • Dipeptides / pharmacology
  • Humans
  • Hydroxamic Acids / pharmacology
  • Metalloendopeptidases / antagonists & inhibitors
  • Metalloendopeptidases / genetics
  • Metalloendopeptidases / metabolism*
  • Mice
  • Mice, Knockout
  • Molecular Sequence Data
  • Protease Inhibitors / pharmacology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Dipeptides
  • Hydroxamic Acids
  • N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide
  • Protease Inhibitors
  • Tumor Necrosis Factor-alpha
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAM17 Protein
  • ADAM17 protein, human
  • Adam17 protein, mouse